-
1
-
-
84962471476
-
Assays for quality control of platelets for transfusion
-
Deckmyn H, Feys HB: Assays for quality control of platelets for transfusion. ISBT Sci Ser 2013; 8:221–224
-
(2013)
ISBT Sci Ser
, vol.8
, pp. 221-224
-
-
Deckmyn, H.1
Feys, H.B.2
-
2
-
-
84927558924
-
In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step
-
Abonnenc M, Sonego G, Kaiser-Guignard J, et al.: In vitro evaluation of pathogen-inactivated buffy coat-derived platelet concentrates during storage: psoralen-based photochemical treatment step-by-step. Blood Transfus 2015; 13:255–264
-
(2015)
Blood Transfus
, vol.13
, pp. 255-264
-
-
Abonnenc, M.1
Sonego, G.2
Kaiser-Guignard, J.3
-
3
-
-
3142592149
-
Implementation of the INTERCEPT Blood System for platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets
-
Janetzko K, Lin L, Eichler H, et al.: Implementation of the INTERCEPT Blood System for platelets into routine blood bank manufacturing procedures: evaluation of apheresis platelets. Vox Sang 2004; 86:239–245
-
(2004)
Vox Sang
, vol.86
, pp. 239-245
-
-
Janetzko, K.1
Lin, L.2
Eichler, H.3
-
4
-
-
33947365171
-
In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage
-
Apelseth TO, Bruserud O, Wentzel-Larsen T, et al.: In vitro evaluation of metabolic changes and residual platelet responsiveness in photochemical treated and gamma-irradiated single-donor platelet concentrates during long-term storage. Transfusion 2007; 47:653–665
-
(2007)
Transfusion
, vol.47
, pp. 653-665
-
-
Apelseth, T.O.1
Bruserud, O.2
Wentzel-Larsen, T.3
-
5
-
-
84927910657
-
Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro
-
Van Aelst B, Feys HB, Devloo R, et al.: Riboflavin and amotosalen photochemical treatments of platelet concentrates reduce thrombus formation kinetics in vitro. Vox Sang 2015; 108:328–339
-
(2015)
Vox Sang
, vol.108
, pp. 328-339
-
-
Van Aelst, B.1
Feys, H.B.2
Devloo, R.3
-
6
-
-
84995810432
-
Psoralen and ultraviolet a light treatment directly affects phosphatidylinositol 3-kinase signal transduction by altering plasma membrane packing
-
Van Aelst B, Devloo R, Zachee P, et al.: Psoralen and ultraviolet a light treatment directly affects phosphatidylinositol 3-kinase signal transduction by altering plasma membrane packing. J Biol Chem 2016; 291:24364–24376
-
(2016)
J Biol Chem
, vol.291
, pp. 24364-24376
-
-
Van Aelst, B.1
Devloo, R.2
Zachee, P.3
-
7
-
-
0037443546
-
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial
-
van Rhenen D, Gulliksson H, Cazenave JP, et al.: Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial. Blood 2003; 101:2426–2433
-
(2003)
Blood
, vol.101
, pp. 2426-2433
-
-
van Rhenen, D.1
Gulliksson, H.2
Cazenave, J.P.3
-
8
-
-
4444380592
-
Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial
-
McCullough J, Vesole DH, Benjamin RJ, et al.: Therapeutic efficacy and safety of platelets treated with a photochemical process for pathogen inactivation: the SPRINT Trial. Blood 2004; 104:1534–1541
-
(2004)
Blood
, vol.104
, pp. 1534-1541
-
-
McCullough, J.1
Vesole, D.H.2
Benjamin, R.J.3
-
10
-
-
85007305879
-
Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres
-
van der Meer PF, Couture C, Hervig T, et al.: Experiences with semi-routine production of riboflavin and UV-B pathogen-inactivated platelet concentrates in three blood centres. Vox Sang 2017; 112:9–17
-
(2017)
Vox Sang
, vol.112
, pp. 9-17
-
-
van der Meer, P.F.1
Couture, C.2
Hervig, T.3
-
11
-
-
79956057782
-
Blood processing
-
Hardwick J: Blood processing. ISBT Sci Ser 2008; 3:148–176
-
(2008)
ISBT Sci Ser
, vol.3
, pp. 148-176
-
-
Hardwick, J.1
-
12
-
-
21644481801
-
Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation
-
Goodall AH, Appleby J: Flow-cytometric analysis of platelet-membrane glycoprotein expression and platelet activation. Methods Mol Biol 2004; 272:225–253
-
(2004)
Methods Mol Biol
, vol.272
, pp. 225-253
-
-
Goodall, A.H.1
Appleby, J.2
-
13
-
-
79851505189
-
Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT Blood System
-
Irsch J, Lin L: Pathogen inactivation of platelet and plasma blood components for transfusion using the INTERCEPT Blood System. Transfus Med Hemother 2011; 38:19–31
-
(2011)
Transfus Med Hemother
, vol.38
, pp. 19-31
-
-
Irsch, J.1
Lin, L.2
-
14
-
-
78651329604
-
In vitro assessment of apheresis and pooled buffy coat platelet components suspended in plasma and SSP+ photochemically treated with amotosalen and UVA for pathogen inactivation (INTERCEPT Blood System™)
-
Chavarin P, Cognasse F, Argaud C, et al.: In vitro assessment of apheresis and pooled buffy coat platelet components suspended in plasma and SSP+ photochemically treated with amotosalen and UVA for pathogen inactivation (INTERCEPT Blood System™). Vox Sang 2011; 100:247–249
-
(2011)
Vox Sang
, vol.100
, pp. 247-249
-
-
Chavarin, P.1
Cognasse, F.2
Argaud, C.3
-
15
-
-
12844263481
-
In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days
-
Moog R, Frohlich A, Mayaudon V, et al.: In vitro evaluation of COM.TEC apheresis platelet concentrates using a preparation set and pathogen inactivation over a storage period of five days. J Clin Apher 2004; 19:185–191
-
(2004)
J Clin Apher
, vol.19
, pp. 185-191
-
-
Moog, R.1
Frohlich, A.2
Mayaudon, V.3
-
16
-
-
67650458193
-
Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction
-
Picker SM, Oustianskaia L, Schneider V, et al.: Functional characteristics of apheresis-derived platelets treated with ultraviolet light combined with either amotosalen-HCl (S-59) or riboflavin (vitamin B2) for pathogen-reduction. Vox Sang 2009; 97:26–33
-
(2009)
Vox Sang
, vol.97
, pp. 26-33
-
-
Picker, S.M.1
Oustianskaia, L.2
Schneider, V.3
-
17
-
-
33644899119
-
In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set
-
Isola H, Kientz D, Aleil B, et al.: In vitro evaluation of Haemonetics MCS+ apheresis platelet concentrates treated with photochemical pathogen inactivation following plasma volume reduction using the INTERCEPT Preparation Set. Vox Sang 2006; 90:128–130
-
(2006)
Vox Sang
, vol.90
, pp. 128-130
-
-
Isola, H.1
Kientz, D.2
Aleil, B.3
-
18
-
-
0029068284
-
A comparative study in volunteers of apheresis and buffy coat derived platelets
-
Mitchell SG, Turner VS, Hawker RJ, et al.: A comparative study in volunteers of apheresis and buffy coat derived platelets. Platelets 1995; 6:146–151
-
(1995)
Platelets
, vol.6
, pp. 146-151
-
-
Mitchell, S.G.1
Turner, V.S.2
Hawker, R.J.3
-
19
-
-
0034059106
-
Are all leucodepleted platelet concentrates equivalent?
-
Krailadsiri P, Seghatchian J: Are all leucodepleted platelet concentrates equivalent? Vox Sang 2000; 78:171–175
-
(2000)
Vox Sang
, vol.78
, pp. 171-175
-
-
Krailadsiri, P.1
Seghatchian, J.2
-
20
-
-
77958469821
-
Function and activation state of platelets in vitro depend on apheresis modality
-
Macher S, Sipurzynski-Budraß S, Rosskopf K, et al.: Function and activation state of platelets in vitro depend on apheresis modality. Vox Sang 2010; 99:332–340
-
(2010)
Vox Sang
, vol.99
, pp. 332-340
-
-
Macher, S.1
Sipurzynski-Budraß, S.2
Rosskopf, K.3
-
21
-
-
62949235839
-
Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: results of a three-arm in vitro study
-
Picker SM, Steisel A, Gathof BS: Cell integrity and mitochondrial function after Mirasol-PRT treatment for pathogen reduction of apheresis-derived platelets: results of a three-arm in vitro study. Transfus Apher Sci 2009; 40:79–85
-
(2009)
Transfus Apher Sci
, vol.40
, pp. 79-85
-
-
Picker, S.M.1
Steisel, A.2
Gathof, B.S.3
-
22
-
-
85032931266
-
In-vivo and in-vitro evaluation of stored platelet products
-
in, Lozano M, Sweeney JD, (eds), Bethesda, MD, AABB Press
-
Heaton WA: In-vivo and in-vitro evaluation of stored platelet products; in Lozano M, Sweeney JD (eds): Platelet Transfusion Therapy. Bethesda, MD, AABB Press, 2013:177–227
-
(2013)
Platelet Transfusion Therapy
, pp. 177-227
-
-
Heaton, W.A.1
-
23
-
-
0036795689
-
Platelet concentrates derived from buffy coat and apheresis: biochemical and functional differences
-
Böck M, Rahrig S, Kunz D, et al.: Platelet concentrates derived from buffy coat and apheresis: biochemical and functional differences. Transfus Med 2002; 12:317–324
-
(2002)
Transfus Med
, vol.12
, pp. 317-324
-
-
Böck, M.1
Rahrig, S.2
Kunz, D.3
-
24
-
-
62949132847
-
Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light
-
Wagner SJ, Skripchenko A, Myrup A, et al.: Evaluation of in vitro storage properties of prestorage pooled whole blood-derived platelets suspended in 100 percent plasma and treated with amotosalen and long-wavelength ultraviolet light. Transfusion 2009; 49:704–710
-
(2009)
Transfusion
, vol.49
, pp. 704-710
-
-
Wagner, S.J.1
Skripchenko, A.2
Myrup, A.3
|